October 21, 2014 1:30 AM ET


Company Overview of Reven Pharmaceuticals, Inc.

Company Overview

Reven Pharmaceuticals, Inc., a development-stage healthcare company, focuses on development of products for the treatment of cardiovascular disease and related vascular disorders due to peripheral arterial disease (PAD), diabetes, and other circulatory disorders. Its product in pipeline includes Rejuveinix for the treatment of coronary artery diseases, PAD, endothelial dysfunction, and critical limb ischemia. The company was formerly known as Noventis, Inc. Reven Pharmaceuticals, Inc. was founded in 1999 and is based in Sarasota, Florida.

4411 Bee Ridge Road

Sarasota, FL 34233

United States

Founded in 1999



Key Executives for Reven Pharmaceuticals, Inc.

Chief Executive Officer
Vice President of Operations
Vice President
Chief Scientist
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Theseus Medical Imaging Corp. United States
G1 Therapeutics, Inc. United States
Alcon Research, Ltd. United States
Fleming and Company Pharamceuticals, Inc. United States
Capsugel Manufacturing, Inc. United States

Recent Private Companies Transactions

Private Placement
February 19, 2014

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Reven Pharmaceuticals, Inc., please visit revenpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.